| A Multiple Dose Study of PF-04950615 (RN316) in Subjects on High Doses of Statins (NCT01342211) | Pfizer | 2011-07-01 |
| Study of the Tolerability, Safety, Pharmacokinetics and Pharmacodynamics of Alirocumab SAR236553 (REGN727) (NCT01448304) | Sanofi | 2011-06-01 |
| A Multiple Dose Study Of PF-04950615 (RN316) In Subjects On Maximum Doses Of Statins (NCT01350141) | Pfizer | 2011-06-01 |
| Multiple Ascending Dose Study of SPC4955 in Healthy Subjects (NCT01365663) | Santaris Pharma A/S | 2011-05-01 |
| Multiple Ascending Dose Study of SPC5001 in Treatment of Healthy Subjects and Subjects With FH (NCT01350960) | Santaris Pharma A/S | 2011-05-01 |
| Efficacy of Cardioviva™ Probiotic Supplement Capsule Formulation (NCT01341613) | Micropharma Limited | 2011-05-01 |
| Ascending Dose Study of the Safety and Tolerability of Alirocumab (SAR236553/REGN727) in Japanese Healthy Volunteers (NCT01448317) | Sanofi | 2011-05-01 |
| Statin Therapy to Improve Medication Adherence (NCT01894217) | Duke University | 2011-05-01 |
| Blood Lipid-lowering Effect of Brown Alga Ecklonia Cava (NCT02091024) | Chonbuk National University Hospital | 2011-04-01 |
| Effects of a Supplement Derived From Palm Oil on Cholesterol Levels in the Blood (NCT02634606) | University of California, Los Angeles | 2011-03-22 |
| The Effects of Pravastatin and Rosuvastatin on Coronary Plaques in Patients With Stable Angina Pectoris (NCT01325818) | Yokohama City University Medical Center | 2011-03-01 |
| Study of the Safety and Tolerability Associated With PPD10558 Versus Atorvastatin in Patients Previously Intolerant to Statins Due to Statin-associated Myalgia (SAM) (NCT01279590) | Furiex Pharmaceuticals, Inc | 2011-03-01 |
| Atorvastatin, Aspirin, Oxidative Stress, Coagulation and Platelet Activation Indexes (NCT01322711) | University of Roma La Sapienza | 2011-03-01 |
| Supplementation of Land-based Stearidonic Acid (SDA)-Rich Oils in Humans (NCT01856179) | University of Jena | 2011-03-01 |
| Pharmacy Home Adherence Reporting and Monitoring Outcomes Study (NCT02306122) | Brown University | 2011-03-01 |
| Lipid-lowering Effect of Plant Stanol Yogurt (NCT01882517) | Raisio Group | 2011-03-01 |
| Injection Site Tolerability, Safety, Pharmacokinetics and Pharmacodynamics Study After a Single Dose Subcutaneous Treatment of Alirocumab SAR236553 (REGN727) (NCT01448239) | Sanofi | 2011-02-01 |
| Cholesterol-lowering Effects of Lupin Protein (NCT01304992) | University of Jena | 2011-02-01 |
| Safety And Tolerability Of Multiple Doses Of PF-04950615 (RN316) In Subjects With Hypercholesterolemia (NCT01243151) | Pfizer | 2011-02-01 |
| High Potency Statins and Acute Kidney Injury (NCT02518516) | Canadian Network for Observational Drug Effect Studies, CNODES | 2011-01-01 |
| Efficacy and Safety Evaluation of Alirocumab (SAR236553/REGN727) in Patients With Primary Hypercholesterolemia on Stable Atorvastatin Therapy (NCT01288443) | Sanofi | 2011-01-01 |
| Lipid-lowering Effect of Plant Stanol Drink (NCT01716390) | Raisio Group | 2011-01-01 |
| Study of the Safety and Efficacy of REGN727/SAR236553 in Patients With HeFH Hypercholesterolemia (NCT01266876) | Regeneron Pharmaceuticals | 2011-01-01 |
| Efficacy and Safety Evaluation of Alirocumab (SAR236553/REGN727) When Co-administered With High Dose of Atorvastatin in Patients With Primary Hypercholesterolemia (NCT01288469) | Sanofi | 2011-01-01 |
| Tailored Communication to Reduce Cardiovascular Risk (NCT01286311) | Northwestern University | 2011-01-01 |
| Cholesterol Lowering Treatment With Psyllium Husks and Isolated Soy Protein in Hypercholesterolemia (NCT01251991) | Aalborg University Hospital | 2011-01-01 |
| Niacin (+) Laropiprant (TREDAPTIVE) Re-examination Study (MK-0524A-119) (NCT01228019) | Merck Sharp & Dohme LLC | 2010-12-01 |
| Polish Survey on the Efficacy of the Hypercholesterolemia Treatment (NCT01243255) | AstraZeneca | 2010-12-01 |
| Effect of Beta-Glucan on Cholesterol Lowering (NCT01408719) | University of Manitoba | 2010-11-01 |
| Study of a Holistic Health Program for United Methodist Clergy (NCT01564719) | Duke Clergy Health Initiative | 2010-10-01 |
| Centralized Pan-Middle East Survey on the Undertreatment of Hypercholesterolemia (NCT01604733) | AstraZeneca | 2010-10-01 |
| Pilot Program to Improve Statin Adherence and Lower Cholesterol in Older Adults (NCT01227330) | University of Missouri-Columbia | 2010-10-01 |
| Statins in Children With Type 1 Diabetes and Hypercholesterolemia (NCT01236365) | Nemours Children's Clinic | 2010-10-01 |
| Randomized Trial of Imaging Versus Risk Factor-Based Therapy for Plaque Regression (NCT01212900) | National Heart, Lung, and Blood Institute (NHLBI) | 2010-09-30 |
| Centralised Pan-Algerian Survey on the Undertreatment of Hypercholesterolemia (NCT01768403) | AstraZeneca | 2010-09-01 |
| Special Drug Use-Results Survey of Lipitor Tablets (NCT01446679) | Astellas Pharma Inc | 2010-09-01 |
| Efficacy of Plant Sterol-Fortified Dairy Product on Plasma Lipid and Plant Sterol Concentrations in Humans (NCT01478789) | University of Manitoba | 2010-09-01 |
| Using Nudges to Implement Comparative Effectiveness (NCT01575171) | NYU Langone Health | 2010-09-01 |
| Effect of Statins on Lipid Levels Following the First Acute Coronary Event (MK-0000-204) (NCT01245738) | Merck Sharp & Dohme LLC | 2010-08-01 |
| Multiple-Dose Safety Study Of RN316 For TheTreatment Of Hypercholesterolemia (NCT01163838) | Pfizer | 2010-08-01 |
| Pharmacokinetic And Pharmacodynamic Study Of A Single-Dose Of PF-04950615 (RN316) In Combination With Atorvastatin (NCT01163851) | Pfizer | 2010-07-01 |
| MK0653C in High Cardiovascular Risk Patients With High Cholesterol (Switch Study)(MK-0653C-162) (NCT01154036) | Organon and Co | 2010-07-01 |
| Primary Prevention of Major Adverse Cardiac Events (MACE) With Standard and Intensive Statin Treatment in Patients With Diabetes: Survival and Cardiovascular Event Assessments (NCT01173939) | Positive Trial Group | 2010-07-01 |
| Amlodipine/Atorvastatin (Caduet®) Drug Use Investigation (Regulatory Post Marketing Commitment Plan) (NCT01107743) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2010-06-01 |
| Ascending Multi-dose Study of REGN727(SAR236553) With and Without Concomitant Atorvastatin (NCT01161082) | Regeneron Pharmaceuticals | 2010-06-01 |
| Effect of Tredaptive on Serum Lipoproteins and Inflammatory Markers (NCT01054508) | Manchester University NHS Foundation Trust | 2010-06-01 |
| Evaluating the Efficacy and Safety of Dehypotin® in the Patients With Type 2 Diabetes Mellitus or Cardiovascular Disease (NCT01108978) | Nang Kuang Pharmaceutical Co., Ltd. | 2010-05-01 |
| The Effect Of Simvastatin On Bone Remodeling In Socket Of Mandibular Teeth (NCT01085149) | Hadassah Medical Organization | 2010-05-01 |
| Safety Study of BMS-844421 for Treatment of Hypercholesterolemia (NCT01082562) | Bristol-Myers Squibb | 2010-04-01 |
| The Effect of Niacin Administration on Oxidative Stress in Patients With Hypercholesterolmia, as Measured by the Use of a Novel Biomarker (NCT01071525) | Rambam Health Care Campus | 2010-04-01 |
| The Efficacy and Safety of Atorva® 20mg Versus Lipitor® 20mg (NCT01624207) | Seoul National University Hospital | 2010-03-01 |
| An Analysis of Diabetes Control in Puerto Rico (NCT01117831) | Center for Diabetes Control, Inc. | 2010-03-01 |
| Metformin in Preventing Androgen Deprivation Therapy Induced Insulin Resistance and Metabolic Syndrome (NCT01077479) | Western Sydney Local Health District | 2010-02-01 |
| Effect of Plant Sterols on the Lipid Profile of Patients With Hypercholesterolaemia (NCT01406106) | Gerencia de Atención Primaria, Albacete | 2010-01-01 |
| Crocus Sativus (Saffron) and Berberis Vulgaris (Barberry Fruit) in Metabolic Syndrome (NCT01625442) | Birjand University of Medical Sciences | 2010-01-01 |
| Plaque REgression With Cholesterol Absorption Inhibitor or Synthesis Inhibitor Evaluated by IntraVascular UltraSound (NCT01043380) | Kumamoto University | 2010-01-01 |
| Effect of Phytosterols Enriched Products Consumption on Carotid Artery Artherosclerotic Plaque (NCT00720720) | French Cardiology Society | 2009-12-16 |
| Different Metabolic Effects of Statins (NCT01011127) | Gachon University Gil Medical Center | 2009-12-01 |
| Influence of Intervention Methodologies on Patient Choice of Therapy (NCT01414751) | University of Southern Denmark | 2009-11-01 |
| Effect of Irbesartan on Endothelial Function of the Retinal Vasculature in Patients With Hypercholesterolemia (NCT00152698) | University of Erlangen-Nürnberg Medical School | 2009-11-01 |
| Centralized Pan-Middle East Survey on the Under-treatment of Hypercholesterolemia, Sub-study for the Gulf States (NCT01031277) | AstraZeneca | 2009-11-01 |
| Centralized Pan-Middle East Survey on the Undertreatment of Hypercholesterolemia (NCT01025388) | AstraZeneca | 2009-11-01 |
| The Effects of Lowering Low-density Lipoprotein Cholesterol Levels to New Targets on Cardiovascular Complications in Peritoneal Dialysis Patients (NCT00999453) | Clinical Research Center for End Stage Renal Disease, Korea | 2009-10-01 |
| Tolerability and Lipid Lowering Effect of Weekly/Biweekly Crestor in Statin Intolerant Patients Treated With Zetia (NCT00972829) | Bronx VA Medical Center | 2009-09-01 |
| LIP-01 in Hypercholesterolemia (NCT00966225) | Afexa Life Sciences Inc | 2009-09-01 |
| Statin Interchange by Pharmacist Collaborative Practice Agreement (CPA) (NCT01222182) | Mayo Clinic | 2009-09-01 |
| Latinos Understanding the Need for Adherence (NCT02955238) | San Diego State University | 2009-08-01 |
| Omega-3 Fatty Acids (Lovaza) for Second Generation Antipsychotic-Associated Hypertriglyceridemia (NCT00833976) | Massachusetts General Hospital | 2009-07-01 |
| Can Cholesterol Lowering Drugs Influence Circulating Omega-3 Fatty Acid Levels (NCT00955227) | University of Manitoba | 2009-07-01 |
| The Effects of Omega-3 Fatty Acid (OMACOR) on the Low-density Lipoprotein (LDL) Sub-fraction in Type 2 Diabetic Patients (NCT00758927) | Inje University | 2009-07-01 |
| Physical Inactivity and Insulin Resistance in Skeletal Muscle. (NCT00536211) | University of Kansas Medical Center | 2009-06-01 |
| Comparison of Simvastatin Versus Simvastatin/Ezetimibe on Small Dense Low -Density Lipoprotein (LDL) (NCT00932620) | University of Ioannina | 2009-06-01 |
| Addition of Ezetimibe (Ezetrol®) to Ongoing Therapy With Rosuvastatin (Crestor®) in HIV Positive Patients Not Reaching Cholesterol Targets (NCT00908011) | University of British Columbia | 2009-06-01 |
| Efficacy and Safety Study of Pitavastatin Versus Atorvastatin to Treat Hypercholesterolemia (NCT01166633) | JW Pharmaceutical | 2009-06-01 |
| Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Pharmacodynamics (PD) of Liposomal siRNA in Subjects With High Cholesterol (NCT00927459) | Arbutus Biopharma Corporation | 2009-06-01 |
| Phytosterols, Ezetimibe, and Cholesterol Metabolism (NCT00863265) | Washington University School of Medicine | 2009-06-01 |
| Cheese Intake and Hypercholesterolemia (NCT01570270) | Azienda Ospedaliera Brotzu | 2009-05-01 |
| Health Benefits of Whole Grain Oats in Population at Risk of Cardio-metabolic Disease (NCT01925365) | University of Reading | 2009-05-01 |
| Effect of Ezetimibe Treatment on Low-density Lipoprotein Cholesterol (LDL-C) Levels in Participants With Coronary Heart Disease (CHD) Already Treated With a Statin (MK-0653A-205 AM1) (NCT01381679) | Organon and Co | 2009-05-01 |
| Primary Prevention of Cardiovascular Diseases in Childhood and Adolescence: the Role of Physical Activity (NCT01580319) | Instituto de Cardiologia do Rio Grande do Sul | 2009-04-01 |
| A Study on the Effects of Soy Protein on Blood Lipids in Men and Women With Mild to Moderate Hypercholesterolemia (NCT00945737) | Solae, LLC | 2009-04-01 |
| Study of MB07811 in Subjects With Hypercholesterolemia (NCT00879112) | Ligand Pharmaceuticals | 2009-04-01 |
| Alternative Options to Minimize Niacin-Induced Flushing (NCT00895193) | Patrick Moriarty, MD, FACP, FACC | 2009-01-01 |
| Long Term Efficacy and Tolerability of a Nutraceutical Combination (Red Yeast Rice, Policosanols and Berberine) in Low-moderate Risk Hypercholesterolemic Patients: a Double-blind, Placebo Controlled Study (NCT02078167) | Comitato Etico di Area Vasta Sud Est | 2009-01-01 |
| Safety and Efficacy of Mipomersen in Patients With Severe Hypercholesterolemia on a Maximally Tolerated Lipid-Lowering Regimen and Who Are Not on Apheresis (NCT00794664) | Kastle Therapeutics, LLC | 2009-01-01 |
| Ezetimibe/Simvastatin (10 mg/40 mg) vs. the Doubling of Atorvastatin in High Risk Participants (MK-0653A-134 AM1)(COMPLETED) (NCT00782184) | Organon and Co | 2008-11-01 |
| Effect of the Molecular Weight of Oat β-glucan on Its Ability to Lower Serum Cholesterol (NCT00981981) | Glycemic Index Laboratories, Inc | 2008-11-01 |
| Safety and Efficacy of Mipomersen (ISIS 301012) As Add-on Therapy in High Risk Hypercholesterolemic Patients (NCT00770146) | Kastle Therapeutics, LLC | 2008-11-01 |
| A Study of Ezetimibe Added On to Rosuvastatin Versus Up Titration of Rosuvastatin in Patients With Hypercholesterolemia (MK0653-139) (NCT00783263) | Organon and Co | 2008-11-01 |
| Bioequivalence Study On Pediatric Appropriate Formulation (NCT00777517) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2008-11-01 |
| Ezetimibe/Simvastatin Combination in Proteinuric Nephropathy (NCT00861731) | Azienda Ospedaliero Universitaria di Sassari | 2008-11-01 |
| Effect of Plant Stanol Ester-Containing Spread on Estimated Cardiovascular Risk in Comparison to Mediterranean Diet (NCT00793364) | Hellenic Atherosclerosis Society | 2008-11-01 |
| Evaluation of Safety and Efficacy of AVE5530 as add-on to Ongoing High Doses of Statins in Patients With Primary Severe Hypercholesterolemia (NCT00766688) | Sanofi | 2008-10-01 |
| Bioequivalence Study Of Pediatric Appropriate Formulation (NCT00758004) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2008-10-01 |
| Safety and Efficacy Study of ISIS 301012 (Mipomersen) Administration in High Risk Statin Intolerant Subjects (NCT00707746) | Kastle Therapeutics, LLC | 2008-10-01 |
| TACTICS (Targeting Adherence to Cholesterol-lowering Therapy to Improve Control Study) (NCT01043354) | Narrows Institute for Biomedical Research | 2008-09-01 |
| Efficacy of Cardioviva™ Probiotic Yogurt Formulation (NCT01185795) | Micropharma Limited | 2008-09-01 |
| Effects of Lactobacillus Delbruckii Lactis DN111244 Fermented Milk Consumption on Plasma Lipids Levels in Hypercholesterolaemic Adults (NCT01353820) | Danone Global Research & Innovation Center | 2008-09-01 |
| Comparison of Pitavastatin With Atorvastatin in Increasing High Density Lipoprotein - Cholesterol (HDL-C) and Adiponectin in Patients With Dyslipidemia and Coronary Artery Disease (CAD) (NCT00861861) | Kumamoto University | 2008-09-01 |
| The Efficacy and Tolerability of Two Formulations of Atorvastatin In Korean Adult With Hypercholesterolemia (NCT01285544) | Seoul National University Hospital | 2008-09-01 |